To the editor: For patients with locally advanced cervical cancer, the current guidelines recommend primary chemoradiation [1]. Therefore, pretherapeutic staging has an important role in the management of female patients with locally advanced cervical cancer. Assessment of the nodal involve ment of the para-aortic lymph node (PALN) is critical for determining the field of radiation therapy (RT). Extended-field RT, concurrent cisplatin-containing chemotherapy, and brachytherapy should be considered in the case of PALN metastasis.
surgical staging in women with locally advanced cervical cancer should be evaluated in future trials, considering the high rate of false-negative PALN involvement from imaging studies. Bearing in mind that postoperative complications and the delay of definite chemoradiation can occur from nodal staging surgery, a comprehensive cost-effective analysis is required to clarify the best treatment strategy for locally advanced stage cervical cancer.
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The purpose of the present study was to evaluate the association between treatment outcomes and the radiologic features of metastatic para-aortic lymph node (PALN) in cervix cancer [1] . As you mentioned, our study has some limitations due to only radiologic evaluations (computed tomography [CT] and magnetic resonance imaging [MRI]) of enlarged PALN (size greater than 1 cm) in most patients except 7 patients who underwent radical surgery and had biopsy proven PALN metastases and 2 with positive uptake on positron emission tomography (PET). To have enough follow-up periods, we included patients between 1994 and 2009. But only after year 2008, PET scan has been a routine study for locally advanced cervical cancer.
Selman et al. [2] pooled a total of 5,042 patients for metaanalysis on diagnostic accuracy of tests for lymph node status in primary cervical cancer. And they found high specificity of 97.6%, 93.2%, and 92.3% with relatively low sensitivity of 74.7%, 55.5%, and 57.5% on PET, MRI, and CT, respectively. Considering unsatisfactory sensitivity of imaging with CT and MRI and heterogeneous group of patients, 3 year overall survival rate of 44% is similar to the previous reports. Among 7 patients who underwent radical surgery and were found to have microscopic PALN metastases only, 4 patients were long-term survivors and the other 3 died within 3 years. Gold analyzed data from Gynecologic Oncology Group (GOG) 120 and GOG 165 showed women with stage III and IV disease in the surgical group had better progression free survival and overall survival compared with those in the radiological group even though selection bias was a problem [3] .
With advanced imaging and surgical technology and to avoid overtreatment with increased complication from extended radiation field or undertreatment, accurate evaluation of PALN metastases including positron emission tomography/ computed tomography is important and has been an essential study in most cancer center. Brockbank et al. [4] thoroughly reviewed pretreatment surgical PALN assessment in locally advanced cervical cancer. They summarized that nonrandomized controlled trial published data, and suggests that surgical staging is more accurate than available imaging modalities with proven safety, and also complete debulking of involved para-aortic nodes appears to translate into a survival advantage. As Brockbank et al. [4] suggested, the decision to offer surgical pretreatment assessment of PALN needs to be individualized.
